Posts in tag
Duchenne muscular dystrophy (DMD)
Solid Bio starts to break up as the ax swings down on one-third of workers, CMO
Amid clinical holds, manufacturing concerns, safety issues and downsized IPOs, Solid Biosciences is bloodletting from its staffers. First, the history: Toward the end of last year, a new clinical hold following serious adverse events formed just part of a long line of setbacks for Solid Bio and the development of its gene therapy for Duchenne …
